These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2689352)

  • 21. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with the use of cefotaxime in the treatment of bacterial meningitis.
    Cherubin CE; Eng RH
    Am J Med; 1986 Mar; 80(3):398-404. PubMed ID: 3513559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cefotaxime monotherapy in bacterial meningitis in childhood].
    Helwig H; Schlegel P
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):733-7. PubMed ID: 3796634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults].
    Portier H; Armengaud M; Becq-Giraudon B; Bousser J; Desbordes JM; Duez JM; Kazmierczak A; Korinek AM; Laisne MJ; Pangon B
    Presse Med; 1987 Dec; 16(43):2161-6. PubMed ID: 2963304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants.
    Chen XK; Shi HY; Leroux S; Xu HY; Zhou Y; Zheng Y; Huang X; Li Y; Jacqz-Aigrain E; Zhao W
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients.
    Urien S; Laurent N; Barre J; Druguet M; Bouvier D'yvoire M; Maire P
    Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pefloxacin in experimental Escherichia coli meningitis.
    Shibl AM; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1986 Mar; 29(3):409-11. PubMed ID: 3521484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cefotaxime CSF levels in children with purulent meningitis (author's transl)].
    Borderon JC; Prieur D; Huguet B
    Nouv Presse Med; 1981 Feb; 10(8):580-4. PubMed ID: 6259596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefotaxime in treatment of meningitis and ventriculitis? Evaluation of drug concentrations in human cerebrospinal fluid.
    Brückner O; Collmann H; Hoffmann HG
    Intensive Care Med; 1982 Jan; 8(1):33-8. PubMed ID: 6276458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of 160 cases of acute bacterial meningitis with cefotaxime.
    Lecour H; Seara A; Miranda AM; Cordeiro J; Sarmento J
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():195-202. PubMed ID: 6094440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
    Dellagrammaticas HD; Christodoulou C; Megaloyanni E; Papadimitriou M; Kapetanakis J; Kourakis G
    Biol Neonate; 2000 Mar; 77(3):139-46. PubMed ID: 10729716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
    Kafetzis DA; Brater DC; Kapiki AN; Papas CV; Dellagrammaticas H; Papadatos CJ
    J Pediatr; 1982 Mar; 100(3):483-9. PubMed ID: 6278118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.
    Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA
    Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.